The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Nitrate Therapy: New Aspects Concerning Molecular Action and Tolerance
Abstract
HomeCirculationVol. 123, No. 19Nitrate Therapy Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBNitrate TherapyNew Aspects Concerning Molecular Action and Tolerance Thomas Münzel, MD, Andreas Daiber, PhD and Tommaso Gori, MD, PhD Thomas MünzelThomas Münzel From II. Medizinische Klinik und Poliklinik, Kardiologie, Johannes Gutenberg Universität, Mainz, Germany. , Andreas DaiberAndreas Daiber From II. Medizinische Klinik und Poliklinik, Kardiologie, Johannes Gutenberg Universität, Mainz, Germany. and Tommaso GoriTommaso Gori From II. Medizinische Klinik und Poliklinik, Kardiologie, Johannes Gutenberg Universität, Mainz, Germany. Originally published17 May 2011https://doi.org/10.1161/CIRCULATIONAHA.110.981407Circulation. 2011;123:2132–2144Although the short-term vasodilatory properties of organic nitrates are potent and well known, a number of vascular and extravascular changes have been shown to compromise their hemodynamic effects on long-term administration. Among these changes, systemic phenomena such as neurohormonal activation and intravascular volume expansion1 as well as specific vascular changes such as increased vascular superoxide (O2·−) production,2 increased sensitivity to vasoconstrictors,3 and decreased responsiveness to nitric oxide (NO) donors4,5 have long been identified as playing a role. Several hypotheses have been proposed to explain these abnormalities, and over the last 15 years, our groups have focused on the concept that an inappropriate production of reactive oxygen species (ROS), an impairment in the scavenging of these mediators (Figure 1), or both might have a crucial mechanistic importance in all these modifications.6,7 Independently of the role of ROS in tolerance, the possibility that nitrate-induced oxidative stress might affect patients' prognosis has important implications, and the observation that long-term therapy with most of the drugs in this class causes endothelial dysfunction, the prognostic significance of which is well accepted in patients with coronary artery disease, hypertension, and heart failure,8 should not be taken as an academic curiosity.Download figureDownload PowerPointFigure 1. Free radical biochemistry. The radical nitric oxide reacts with superoxide to form the highly reactive intermediate peroxynitrite. Superoxide is dismutated by superoxide dismutase (SOD), leading to the formation of hydrogen peroxide (H2O2) and molecular oxygen (O2).Beyond these as-yet insufficiently investigated prognostic implications, recognition of the role of ROS suggests that a number of interventions thought to interfere with the vascular redox balance might also retard or prevent the development of nitrate tolerance and nitrate-induced side effects. Evidence that therapy with angiotensin-converting enzyme (ACE) inhibitors, angiotensin-1 receptor blockers, certain β-blockers, statins, and vitamins such as folic acid or vitamin C beneficially influence nitrate tolerance and glyceryl trinitrate (GTN)–induced endothelial dysfunction suggests that nitrate therapy might have profoundly different implications since these therapies have become diffusely available. In addition, the recognition of important differences in the mechanisms triggered by different nitrates should also be attributed clinical relevance, and evidence suggests that, rather than the generic nitrate tolerance, more specific expressions (GTN tolerance, isosorbide mononitrate [ISMN] tolerance, etc) should be used.9 This review summarizes the current concepts underlying tolerance and endothelial dysfunction in response to long-term therapy with different nitrates and addresses the question of whether the use of these drugs remains indicated despite these side effects.The Hemodynamic Effects of NitratesVenous capacitance vessels, large and medium-sized coronary arteries, and collateral vessels are most sensitive to GTN, whereas coronary and peripheral arterioles with a diameter <100 μm are relatively more resistant. In the setting of stable angina, the preferential venodilatation induced by antiischemic doses of GTN results in venous pooling and preload reduction, yielding reduced left ventricular filling pressure and wall tension. As a result of these changes, myocardial workload and oxygen demand decrease (Figure 2). Beyond this effect, the clinical benefit of organic nitrates in the setting of acute coronary syndromes is thought to depend primarily on the dilation of epicardial coronaries and coronary collaterals, improving perfusion and oxygen delivery to subendocardial regions by increasing total coronary conductance. Furthermore, because the tone and caliber of myocardial resistance vessels are almost unaffected, coronary steal phenomena and reflex tachycardia are in general avoided. In summary, the mismatch between oxygen demand and suppl
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Is oxidative stress a therapeutic target in cardiovascular disease?
Münzel, T., Gori, T., Bruno, R. M., & Taddei, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq396 · Cited by 470
Self-citationDaiber, A. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.01.032 · Cited by 347
Self-citationMünzel, T., Feil, R., Mülsch, A., Lohmann, S. M., Hofmann, F., & Walter, U. (2003) · Circulation · doi:10.1161/01.cir.0000094403.78467.c3 · Cited by 316
Sydow, K., Daiber, A., Oelze, M., Chen, Z., August, M., Wendt, M., Ullrich, V., Mülsch, A., Schulz, E., Keaney, J. F., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419267 · Cited by 300
Self-citationGori, T., Burstein, J. M., Ahmed, S., Miner, S. E. S., Al-Hesayen, A., Kelly, S., & Parker, J. D. (2001) · Circulation · doi:10.1161/hc3501.095358 · Cited by 178
Self-citationDietary supplement with vitamin C prevents nitrate tolerance
Bassenge, E., Fink, N., Skatchkov, M., & Fink, B. (1998) · Journal of Clinical Investigation · doi:10.1172/jci977 · Cited by 138
Gogia, H., Mehra, A., Parikh, S., Raman, M., Ajit-Uppal, J., Johnson, J. V., & Elkayam, U. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00368-1 · Cited by 137
Cited by
Targeting vascular (endothelial) dysfunction
Daiber, A., Steven, S., Weber, A., Shuvaev, V. V., Muzykantov, V. R., Laher, I., Li, H., Lamas, S., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13517 · Cited by 501
Self-citationJCS Joint Working Group (2014) · Circulation Journal · doi:10.1253/circj.cj-66-0098 · Cited by 459
Egea, J., Fabregat, I., Frapart, Y. M., Ghezzi, P., Görlach, A., Kietzmann, T., Kubaichuk, K., Knaus, U. G., Lopez, M. G., Olaso-Gonzalez, G., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.007 · Cited by 310
Self-citationDaiber, A., Xia, N., Steven, S., Oelze, M., Hanf, A., Kröller-Schön, S., Münzel, T., & Li, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010187 · Cited by 297
Self-citationKapil, V., Khambata, R. S., Jones, D. A., Rathod, K., Primus, C., Massimo, G., Fukuto, J. M., & Ahluwalia, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019240 · Cited by 248
Metadata
- Authors
- Münzel, T., Daiber, A., & Gori, T.
- Venue
- Circulation
- Published
- 2011-05-17
- Volume
- 123
- Issue
- 19
- Pages
- 2132-2144
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2104096646
- Cited by
- 197
- References
- 8
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nitrate Therapy: New Aspects Concerning Molecular Action and Tolerance. https://app.cochat.ai/papers/10.1161/circulationaha.110.981407
- The paper
- Münzel, T., Daiber, A., & Gori, T. (2011). Nitrate Therapy: New Aspects Concerning Molecular Action and Tolerance. Circulation. https://doi.org/10.1161/circulationaha.110.981407
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.